EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SuperRCA assay of KIT p.D816V mutation load reveals novel correlation to clinical phenotype

Cecilia Karlström, Monika Klimkowska, Marie Engvall, Sofia Nordin, Ebba Westerberg, Sofia Papavasileiou, Joakim S Dahlin, Johanna Ungerstedt

Journal of Allergy and Clinical Immunology: Global · 2026-11 · 5 (6) · 100778

DOI: 10.1016/j.jacig.2026.100778 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology: Global, 2026-11. Verfasst von Cecilia Karlström und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Huddinge, Sweden. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Cancer Society, Center for Innovative Medicine, Swedish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The KIT p.D816V mutation is seen in more than 90% of patients with systemic mastocytosis (SM). A high variant allele fraction (VAF) is associated with adverse outcome; however, no correlations betwen mutation burden and clinical symptoms have hitherto been established.

Objective

Our aim was to quantify KIT p.D816V VAF in blood and bone marrow (BM) by using the ultrasensitive superRCA method and correlate the VAF with clinical symptoms.

Method

A total of 107 blood and BM samples from patients with SM were analyzed.

Results

In 78 of the 107 samples, a DNA input concentration of 660 ng was used to obtain a sensitivity for KIT p.D816V mutation of 0.0016% VAF. In paired analysis, level of KIT p.D816V VAF was significantly higher in BM than in blood, and it correlated with SM disease burden (ie, serum tryptase level and percentage of BM mast cell infiltration). No correlations were found between VAF and anaphylaxis, osteoporosis, or gastrointestinal symptoms. Among the patients with indolent SM (ISM), those with skin involvement had a higher blood VAF despite a similar percentage of BM mast cell infiltration.

Conclusion

By using SuperRCA KIT p.D816V detection, we demonstrated that in the blood of patients with ISM, VAF is higher in patients with mastocytosis in the skin than in the patients without skin involvement, leading us to hypothesize that circulating KIT p.D816V-mutated progenitors with mast cell potential may drive the cutaneous phenotype. In addition, our findings in paired blood and BM samples support the findings of previous studies and provide further evidence supporting higher VAFs in BM than in blood as well as a correlation of VAF with disease burden.

Schlagwörter

Stichwörter der Autor:innen

KIT mutationmast cellsuperRCAsystemic mastocytosis

Autor:innen und Institutionen

  • Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Huddinge, Sweden.
  • ME Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
  • Rarity Bioscience AB, Uppsala, Sweden.
  • Department of Medicine Solna, Karolinska Institutet, Center for Molecular Medicine, and Karolinska University Hospital, Stockholm, Sweden.

Förderung

  • Swedish Cancer Society
  • Center for Innovative Medicine
  • Swedish Research Council

Zitieren

APA

Karlström, C., Klimkowska, M., Engvall, M., Nordin, S., Westerberg, E., Papavasileiou, S., Dahlin, J. S., & Ungerstedt, J. (2026). SuperRCA assay of KIT p.D816V mutation load reveals novel correlation to clinical phenotype. Journal of Allergy and Clinical Immunology: Global, 5(6), 100778. https://doi.org/10.1016/j.jacig.2026.100778

Vancouver

Karlström C, Klimkowska M, Engvall M, Nordin S, Westerberg E, Papavasileiou S, et al. SuperRCA assay of KIT p.D816V mutation load reveals novel correlation to clinical phenotype. Journal of Allergy and Clinical Immunology: Global. 2026;5(6):100778. doi:10.1016/j.jacig.2026.100778

BibTeX
@article{Karlstrm2026,
  author = {Karlström, Cecilia and Klimkowska, Monika and Engvall, Marie and Nordin, Sofia and Westerberg, Ebba and Papavasileiou, Sofia and Dahlin, Joakim S and Ungerstedt, Johanna},
  title = {SuperRCA assay of KIT p.D816V mutation load reveals novel correlation to clinical phenotype},
  journal = {Journal of Allergy and Clinical Immunology: Global},
  year = {2026},
  volume = {5},
  number = {6},
  pages = {100778},
  doi = {10.1016/j.jacig.2026.100778}
}
Kostenlos starten →